Advancing Antibody Discovery and Vaccine Development with Lipoparticles and Reporter Viruses
Innovative tools have been instrumental for rapid advancements in therapeutic antibody and vaccine research and development. This webinar focuses on critical reagents developed by Integral Molecular, a pioneer in membrane protein and virology research tools.
Lipoparticles are virus-like particles that present high-concentration, native-conformation membrane proteins for immunization, antibody screening and antibody characterization. Reporter Virus Particles (RVPs) are pseudotyped, virus-like particles that enable consistent, high-throughput studies at BSL-2 for evolving and highly pathogenic viruses.
Speakers
Dr. Christina K. Go
Virology | Integral Molecular
Dr. Christina K. Go earned her Ph.D. in biomedical sciences from the Lewis Katz School of Medicine at Temple University, studying membrane protein interactions in T cell activation, followed by a research fellowship at the University of Pennsylvania in immunology and infectious diseases. She and the Virology group at Integral Molecular develop tools to accelerate vaccine and therapeutic development for current and emerging viral pathogens.
Meghan Pitts
Integral Molecular
Meghan Pitts graduated from Drexel University and has over ten years of experience in membrane protein expression and antibody discovery for pre-clinical and clinical applications, contributing to four peer-reviewed publications. At Integral Molecular she supports customers at all stages of their projects, from understanding their goals to providing reagents and services.
Key Learning Objectives
- Using RVPs to generate reproducible virus neutralization assays for clinical and preclinical vaccine development
- Case studies of RVPs in vaccine development and therapeutic research for SARS-CoV-2 and dengue viruses
- Using Lipoparticles to advance research on complex membrane proteins and receptors such as chemokine receptors and GPCRs
- Interactive Q&A with the experts
Watch Now: Advancing Antibody Discovery and Vaccine Development with Lipoparticles and Reporter Viruses
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- July 31, 2024
- Dr. Christina K. Go, Integral Molecular
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and you'll go straight to the recording — we'll also email you the link.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar